chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got tinnitus in both ears about 1 week after the first dose and it hasnt gone away.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 23Mar2021 (Lot number: ER2613) at the age of 62 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious) with onset 29Mar2021, outcome "not recovered", described as "I got tinnitus in both ears about 1 week after the first dose and it hasnt gone away.". Therapeutic measures were not taken as a result of tinnitus.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient did not tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Information has been received from a health professional concerning a patient who was vaccianted with the first and second dose of Varivax (Oak/Merck). Subsequently the patient experienced lesions. It was noted that the patient's titer was negative. No further information was provided. Follow up information indicated that there was no other information. No additional information is expected.
Debilitating headache within 1-1/2 hours of administration of FLUARIX injection, lasting approximately 36 hours. Tachycardia within 15 minutes, dizziness, lasting approximately 12 hours.
Breakthrough case. Thought allergies was acting up real bad, but started getting worse and had chills and was congested. Went to Urgent Care and tested positive for COVID-19. They sent me to have an Infusion because I have 2 different lung diseases. Was sick for 2 weeks, then started to get a little better. But for 2 months I was short of breath.  Am also left with severe migraines. Feeling better, but still suffer with migraines.
patient with pain, Erythema, warmth and edema  at and below site of vaccination within 24 hr of administration.
nausea; aches; pains; arm sore to the touch; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches), PAIN (pains), CHILLS (chills), PAIN IN EXTREMITY (arm sore to the touch) and NAUSEA (nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included IBUPROFEN and OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PAIN (aches), PAIN (pains), CHILLS (chills) and PAIN IN EXTREMITY (arm sore to the touch). On 14-Apr-2021, the patient experienced NAUSEA (nausea). At the time of the report, PAIN (aches), PAIN (pains), CHILLS (chills), PAIN IN EXTREMITY (arm sore to the touch) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.    Treatment products included Ibuprofen.   Reporter did not allow further contact
pt recvd vax; had red sore swollen area on lt upper arm,size approx 2x3cm; warm to touch;mom states fever x 2 days;not measured but very warm to touch; apap given;
hospital visit, increased b/p, pain in center of sternum, tingly limbs, bottom of feet felt burned, dx of Epigastric abdominal pain,  vomiting 48 hours, dr visit, hospital visit for dehydration, lack of smell and  taste, tingly limbs gone but severe pain  behind right knee, ruled out blood clot, smell back, taste  not all the way returned, pain continuous
Pt recvd vax & exp severe pain @ the inject site & the entire arm; CNS involvement consisting of tingling, numbness & heaviness in the inject arm, lightheadedness, dizziness; No further details were provided;
Vaccine put in the fridge on 07Feb2022 and doses were administered on 20APR2022; expired doses of Moderna COVID-19 were administered beyond the beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired doses of Moderna COVID-19 were administered beyond the beyond use date) and PRODUCT STORAGE ERROR (Vaccine put in the fridge on 07Feb2022 and doses were administered on 20APR2022) in an 87-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 083J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired doses of Moderna COVID-19 were administered beyond the beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine put in the fridge on 07Feb2022 and doses were administered on 20APR2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired doses of Moderna COVID-19 were administered beyond the beyond use date) and PRODUCT STORAGE ERROR (Vaccine put in the fridge on 07Feb2022 and doses were administered on 20APR2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   As per report Patient received 2nd booster dose   No concomitant medications were provided.  For LOT 083J21A the vials were initially stored in the refrigerator On 07 FEB 2022 ,. The vial did not undergo any temperature excursions.  No treatment medications were provided.
Tested positive for Covid on 5/16. Contacted doctor on 5/17 and RX'd Paxlovid.
Patient states she developed a fever up to 105 on 08/18/2005 after having TD booster and Menactra vaccine on 08/17/2005. Fevers off and on for next several days, felt headache, lethargy, came back to clinic on 08/22/2005 for followup
no appetite; Fatigue; soreness of the injection site; Diarrhoea; vomiting; stomach cramp; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhoea), VOMITING (vomiting), ABDOMINAL PAIN UPPER (stomach cramp), DECREASED APPETITE (no appetite) and FATIGUE (Fatigue) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced DIARRHOEA (Diarrhoea), VOMITING (vomiting) and ABDOMINAL PAIN UPPER (stomach cramp). On 11-Mar-2021, the patient experienced DECREASED APPETITE (no appetite), FATIGUE (Fatigue) and VACCINATION SITE PAIN (soreness of the injection site). At the time of the report, DIARRHOEA (Diarrhoea), VOMITING (vomiting), ABDOMINAL PAIN UPPER (stomach cramp), DECREASED APPETITE (no appetite), FATIGUE (Fatigue) and VACCINATION SITE PAIN (soreness of the injection site) outcome was unknown. Not Provided          Relevant concomitant product usage were not reported by the reporter. No treatment details were added.    Reporter did not allow further contact
Administer expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) in a 39-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine). On 23-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment was given.  The vaccine was stored in freezer, one to two vials were taken out and placed in the fridge each day as needed
PATIENT REPORTED FEELING SICK TO HER STOMACH A MINUTE AFTER  VACCINE ADMINISTRATION
I was born in another country so I received the BCG vaccine. I have a little scar on my arm from when I got the vaccine. After getting the Covid vaccine, I noticed that my BCG vaccine scar was red, raised, and hard. It looked like a little induration.
This spontaneous report as received from a registered nurse refers to a 10 month old patient. On 23-AUG-2012 the patient was vaccinated subcutaneously with 0.5 ml dose of VARIVAX (lot# not reported). No adverse effect reported. Additional information has been requested.
mother of the patient believes the patient inadvertently received the "wrong vaccinations"; This spontaneous report was received from a medical assistant, referring to a 12-month-old patient of unknown gender. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies, and concomitant therapies were not reported.  According to the medical assistant, the patient's mother believed that on 13-NOV-2019, the patient was inadvertently vaccinated with a dose of hepatitis b vaccine (recombinant) (thimerosal free)(RECOMBIVAX HB) lot number R021372 expiration date 25-MAY-2021, as prophylaxis (strength, vaccination regimen and route of administration were not provided).  The patient's mother believed the patient inadvertently received the wrong vaccinations (wrong product administered) on 13-NOV-2019; she believed that the vaccinations administered were intended for her younger child. However, the medical assistant reported that the patient was supposed to receive doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II); varicella virus vaccine live (oka/merck) (VARIVAX); and hepatitis a vaccine, inactivated (VAQTA) (strength, dose, vaccination regimen, route of administration, lot numbers, and expiration dates were not provided) which, according to their documentation, were indeed administered to the patient on that same date as prophylaxis. It was reported by the medical assistant that the patient's mother had a history of post-partum depression.  At the time of this report, the outcome of wrong product administered was unknown.
Narrative:  01/11 COVID vaccine dose #1-no reaction 02/09 COVID vaccine dose #2-no reaction 11/10 COVID vaccine dose #3 @11:02am and was monitored for 15 minutes then left the clinic. Pt returned to clinic at 12:10pm and stated that his right upper lip felt puffy and slightly numb. There was no change of color to his skin on his right upper lip/cheek. No visible puffiness/swelling observed on upper right lip/cheek. Pt sat in the normal monitoring station for an addition 30 minutes, drank water and stated the symptoms were much better before leaving.
After vaccine, the next day 3-4am woke up with horrible headache, slight fever, sweaty. injection site raised and red and still is, also has trouble keeping  liquid or food in.  Still gets fleeting headaches and sweats ever morning.
Information have been received from the register nurse and a hospital central service technician, for GARDASIL, a Pregnancy Registry product, concerning an 18 year old female patient who on 23-JUN-2009 was vaccinated with a first dose of GARDASIL (lot#661846/1312X, route and site not reported) and a dose of MENACTRA (Sanofi Pasteur, lot#U2872AA). The patient was pregnant, the menstrual period was in May 2009, and the estimated delivery date was 05-Feb-2010. The hospital central service technician who was the patient's grandmother reported that the patient did not want to pregnant and was experiencing multiple relationship problems. "Something happened to her after she became pregnant. She did not sound like herself". On 22-JUL-2009, the patient contacted her grandmother and reported she was hyperventilating. The patient's father took her to the hospital on 23-JUL-2009 and she was admitted. On 24-JUL-2009, the patient was placed in the ICU. On 25-JUL-2009, she was transferred to the crisis unit. The grandmother visited the patient on 01-AUG-2009. The patient's eyes were dilated and she only communicated with a few words instead of complete sentences or by shaking her head. The nurse said that the patient was in a type of shock and was experiencing a chemical imbalance. At the time of reporting, the patient did not recover and was still hospitalized. Additional information has been requested.  8/24/09 Hospital records received DOS 7/23/09 to 8/10/09. Assessment: Major depressive disorder, anxiety disorder, pregnancy. Patient presents with psychomotor slowing. Stares for extended periods of time without answering. Thought blocking. Not responding to internal stimuli. Eating poorly, nausea and vomiting. Affect blunted. Dehydrated. Auditory hallucinations and suicidal ideation. Haldol - acathesia.  ICD-9 Codes 648.43 Mental disorder complicating pregnancy antepartum condition or complication, 296.24 Major depression single episode severe with psychotic behavior, 300.0 Anxiety states, 646.63 Genitourinary tract infection in pregnancy antepartum condition or complication, 590.0 Chronic pyelonephritis, 643.13 Hyperemesis gravidarum with metabolic disturbance antepartum condition or complication, 276.51 Dehydration, 276.8 Hypokalemia, 780.52 Insomnia unspecified.
Systemic: Lymph Node Swelling-Medium, Additional Details: per patient; lymph nodes swollen: armpit, shoulder, neck
Information has been received from a health professional concerning a child in third grade who was vaccinated with a dose of Varivax. On 03-APR-2006 the patient experienced shingles. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
PT had fever which lead to 2 days off of work. Left shoulder area vaccination site with erythema and minmal tenderness and slight increase of warth. LT axilla is slightly tender with not evident lymphadenopathy. PT was given cetirizine.
Patient was given Janssen instead of a second dose of Pfizer. The vaccinator delivered the wrong vaccine to the patient. The patient was immediately informed. It was explained to her as well that she will not need to return for her 2nd dose of Pfizer and that current CDC guidelines do not recommend revaccination.
I felt "speedy"  and had to stay seated after the shot.  I could not leave to drive. I felt breathless.  I went home and felt okay, but next day I woke   up feeling breathless all day.  That was on the 17th. On the 18th I felt pressure on my chest and I had to sit up.
On Mar 31, low grade fever and chills began at 10:30 pm.  Weakness began at 11:30 p.m. to the point that I could barely stand and couldn't walk without assistance.   Also experienced headache and quick and shallow breathing.  Extreme fatigue lasted until Apr 2.
sudden onset of flu-like sx including fever, chills, chest discomfort, pain in eyes;
pt recvd vax 7FEB96 & hrs later exp inc irritability (w/screaming, mucous from the nose flying all over the place) then quiet as chief complaint;somnolence;head held to rt w/failure to track-(eye at half mast)
Have picture of  approx. 4? diameter swelling, redness and Hot around injection site.  In spite of cold compress swelling, redness, and heat remained unchanged throughout 3rd day.    Now, 4th day,  redness, swelling and heat are subsiding.  No other physical symptoms.  Is it safe to get 2nd vaccine shot?
Patient began to get a fever of 100 F the evening of his vaccination 11/7/17. Motrin was given and  pt went to bed. His fever was 102 F the next morning 11/8/17. Motrin was given and doctor appointment made. His temperature was normal at 9:30am at doctor office. Then that evening (11/8/17) his fever came back to 102F. Motrin was given and he went to bed. His temperature was 99F at midnight. Then fever 102 again the morning of 11/9/17. Motrin alternating with Tylenol given  rest of day. Finally normal at bedtime 11/9/17.
never got the 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received the first dose 3 years ago from reporting).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: never got the 2nd dose). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 14-AUG-2023 Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. No additional information provided.
On Day 7 after vaccine date , the area of injection became red, swollen, hot and very itchy.  Stayed this way for 4 days.  Still, at 14 days after vaccine the site is a dusky brown.
I went from consistent 3-4 day consistent light mild bleeding with 3.5 weeks between of no bleeding to 7-8 day periods that are very very heavy the whole time and then dark discharge after that with only 2-2.5 weeks between of no bleeding.  It has not gotten lighter or shorter six periods since.  Many friends who have not reported say they have same thing.  People don?t know where to report and I finally decided I had to report since it?s not going away.  I have also started getting migraines recently which I never have gotten.
This spontaneous report as received from a pharmacist refers to a currently 56 years old male patient. The patient's medical history included shingles prior July 2013. In July 2013, the patient was vaccinated with ZOSTAVAX lot # J000443; expiration date: 11-APR-2014, 0.65 ml, subcutaneous. Secondary and concomitant therapies were not reported. The patient's wife reported to the pharmacist that since the vaccination in July 2013, the patient had an unknown number of outbreaks of shingles, but these outbreaks were less severe than his outbreaks of shingles prior to receiving ZOSTAVAX. The outcome of shingles was reported as recovered on an unknown date. Additional information has been requested.
I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 4/23/2023 GI HEMORRHAGE I82.402 ACUTE DVT OF LEFT LEG, UNSPECIFIED VEIN 4/23/2023 MULTIPLE SCLEROSIS
pt recv vax & bumped head when fell to floor probable fainting episode;VS WNL;color return to nl in 20min;pt walk to car w/assistance;given head injury & allergic rxn sx;mom to observe child throughout day;
Starting day 5: extremely painful and inflamed lymph nodes,  particularly under arms. Day 9: developed Cellulitis in left upper arm at injection site
we both got COVID possitive PCRs results.; we both got COVID possitive PCRs results.; minor pain; This is a spontaneous report from Pfizer. A contactable consumer reported for a female patient (daughter).  A 12-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter reported that the reporter received vaccine back in Apr and the patient (daughter) just turned 12 on Jul2021. We travelled to get her 2nd dose and unfortunately, we both got COVID positive PCRs results on an unspecified date. Our main purpose was to thank all the Pfizer team, for creating the vaccine. Honestly, we had minor pain and issues while going through COVID, still will be isolated for 10 more days and wanted to thank you and all the Pfizer team for creating this. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on we both got COVID positive PCRs results on an unspecified date. Outcome of the events was unknown.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
Patient woke apx 0200 complaining of nausea to group home staff.  Vitals were checked at that time and WNL.  Patient went back to bed.  When staff went to wake patient apx 0530, he was unresponsive and had no pulse. Chest compressions were started and EMS called.
General soreness in my arm; Chills; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (General soreness in my arm), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 602A21A and 022L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CELECOXIB (CELEBREX) for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (General soreness in my arm), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (General soreness in my arm), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-378077, MOD-2021-378105 (Patient Link).
This spontaneous report as received from a pharmacist via company representative refers to a female patient of unknown age. On an unknown date in October 2014 the patient was vaccinated with a dose of ZOSTAVAX in the left arm (dose, route and lot number were not reported). One week after the administration, the patient stated to the pharmacist that she had pain and discomfort in her right arm (onset date was not provided, estimated in 2014). The patient sought medical attention by contacting the pharmacist. The outcome of discomfort and pain in her right arm was unknown. Relatedness between the therapy and the events was not provided. Additional information has been requested.
hard lump; itchiness; This is a spontaneous report from a contactable healthcare professional and a pharmacist. A patient of unspecified age and gender started to receive pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration on 07Oct2020 at single dose for immunization. Medical history and concomitant medications were not reported. Patient experienced a hard lump and itchiness on an unspecified date. Patient was coming in to be seen by the pharmacist and sent to primary care based on recommendation. Outcome of the events was unknown.  No follow-up attempts are needed, information about lot/batch number cannot be obtained.
PT states she got the Pfizer vaccine on her left arm on 9/21/2021 and was told to wait 15 mins. During that period she started feeling her arm tingling and numb. She decided to stay longer. After 20-25 mins she felt better and left. Nothing else happened until the next morning when she woke up and her arm was numb and one of her fingers is numb on the tip. Since 9/22/2021 she's been having the same symptoms, not everyday but frequently. she states that she never had those symptoms prior the vaccine. She also stated she didn't experience those symptoms with her first dose.